<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04122807</url>
  </required_header>
  <id_info>
    <org_study_id>114445</org_study_id>
    <nct_id>NCT04122807</nct_id>
  </id_info>
  <brief_title>Cryoablation of the Retrograde Fast Pathway as Treatment for AVNRT</brief_title>
  <acronym>Cryo-FP</acronym>
  <official_title>Cryoablation of the Retrograde Fast Pathway as Treatment for AVNRT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Western Ontario, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study a new technique for ablation in atrioventricular nodal reentrant tachycardia
      using cryo-energy will be studied in cases where the standard approach has higher risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common cause of fast
      heartbeats in young people. People with AVNRT have two pathways within the heart, the fast
      pathway (FP) and slow pathway (SP). A treatment for AVNRT is ablation (burning or freezing)
      of the SP. This can be done with either radiofrequency or cryo-energy. A complication which
      occurs in 1% of cases is AV block (AVB), meaning the person needs a pacemaker.

      Slow pathway ablation is a problem in people when the electrocardiogram (ECG) shows a long PR
      interval, with greater rates of AVB. This accounts for 5% of AVNRT cases. A possible solution
      is to treat the FP with cryo-energy and leave the SP intact. This pilot study aims to show
      this is safe and effective.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective model with two groups based on PR interval on ECG, normal and prolonged PR</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Termination of AVNRT</measure>
    <time_frame>One day</time_frame>
    <description>Number of participants where cryotherapy terminates AVNRT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Freedom from recurrence</measure>
    <time_frame>1 year</time_frame>
    <description>Number of participants with no recurrence of AVNRT during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of AV block</measure>
    <time_frame>1 year</time_frame>
    <description>Number of participants where AV block is observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac tamponade</measure>
    <time_frame>1 year</time_frame>
    <description>Number of participants with pericardial effusion and/or tamponade following procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular complications</measure>
    <time_frame>1 year</time_frame>
    <description>Number of participants with groin hematoma or fistula requiring intervention following procedure</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Procedural time</measure>
    <time_frame>Immediate</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>Immediate</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Atrioventricular Node Arrhythmia</condition>
  <arm_group>
    <arm_group_label>Mapping</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment involving ablation of the slow pathway with cryotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mapping and ablation of the retrograde fast pathway with cryotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac catheter ablation</intervention_name>
    <description>Cryoablation</description>
    <arm_group_label>Ablation</arm_group_label>
    <arm_group_label>Mapping</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented supraventricular tachycardia (SVT)

          -  Planned to undergo electrophysiology (EP) study and ablation

          -  PR interval on ECG &lt;220ms (Group 1) or &gt;220ms (Group 2)

        Exclusion Criteria:

          -  Pregnancy

          -  Age &lt;18 years

          -  Inability to provide consent

          -  High likelihood of tachycardia mechanism other than AVNRT (e.g. Pre-excitation on
             surface ECG, atrial tachycardia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matthew K Rowe, MBBS</last_name>
    <phone>1-519-663-3746</phone>
    <email>matthew.rowe@lhsc.on.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Allan Skanes, MD</last_name>
    <phone>1-519-663-3746</phone>
    <email>allan.skanes@lhsc.on.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lawson Health Research Institute</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew K Rowe, MBBS</last_name>
      <phone>1-519-663-3746</phone>
      <email>matthew.rowe@lhsc.on.ca</email>
    </contact>
    <contact_backup>
      <last_name>Allan Skanes, MD</last_name>
      <phone>1-519-663-3746</phone>
      <email>allan.skanes@lhsc.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Allan Skanes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew K Rowe, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 2, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AVNRT</keyword>
  <keyword>Cryoablation</keyword>
  <keyword>PR interval</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

